RECURRENT CERVICAL CARCINOMA
Clinical trials for RECURRENT CERVICAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT CERVICAL CARCINOMA trials appear
Sign up with your email to follow new studies for RECURRENT CERVICAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Promising drug combo targets recurrent gynecologic cancers
Disease control Recruiting nowThis early-stage study tests a drug called talazoparib combined with radiation therapy for people whose gynecologic cancer (like ovarian, uterine, or cervical) has returned. The goal is to find the safest dose and see if the combination can shrink tumors. About 24 participants wi…
Matched conditions: RECURRENT CERVICAL CARCINOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 03:33 UTC
-
New combo therapy aims to revive immune attack on hard-to-treat cervical cancer
Disease control Recruiting nowThis study tests whether adding an experimental drug (PRGN-2009) to the existing immunotherapy pembrolizumab can shrink tumors in people with advanced cervical cancer that no longer responds to pembrolizumab alone. About 24 adults with HPV-positive, recurrent or metastatic cervic…
Matched conditions: RECURRENT CERVICAL CARCINOMA
Phase: PHASE2 • Sponsor: Precigen, Inc • Aim: Disease control
Last updated May 26, 2026 03:32 UTC
-
New platform aims to predict which cancer treatments will work
Knowledge-focused Recruiting nowThis study collects tissue samples from people with various advanced or early-stage cancers to train a diagnostic platform called Elephas. The goal is to see how accurately it can predict whether a patient will respond to immunotherapy or chemoimmunotherapy. About 324 participant…
Matched conditions: RECURRENT CERVICAL CARCINOMA
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 26, 2026 03:28 UTC